Status of BetaCage: an Ultra-sensitive Screener for Surface Contamination

BetaCage, a gaseous neon time-projection chamber, has been proposed as a viable screener for emitters of low-energy alphas and electrons to which commercial radioactivity counting techniques are insensitive. Using radiopure materials for construction, active and passive shielding from extrinsic backgrounds, large counting area and minimal detector mass, BetaCage will be able to achieve sensitivities of 10^(−5) counts keV^(−1) kg^(−1) day^(−1) in a few days of running time. We report on progress in prototype development work since the last meeting of this workshop

Site specific spin dynamics in BaFe2As2: tuning the ground state by orbital differentiation

The role of orbital differentiation on the emergence of superconductivity in the Fe-based superconductors remains an open question to the scientific community. In this investigation, we employ a suitable microscopic spin probe technique, namely Electron Spin Resonance (ESR), to investigate this issue on selected chemically substituted BaFe$_{2}$As$_{2}$ single crystals. As the spin-density wave (SDW) phase is suppressed, we observe a clear increase of the Fe 3$d$ bands anisotropy along with their localization at the FeAs plane. Such an increase of the planar orbital content interestingly occurs independently on the chemical substitution responsible for suppressing the SDW phase. As a consequence, the magnetic fluctuations combined with the resultant particular symmetry of the Fe 3$d$ bands are propitious ingredients to the emergence of superconductivity in this class of materials.Comment: 6 pages, 5 figure

The BetaCage, an ultra-sensitive screener for surface contamination

Material screening for identifying low-energy electron emitters and alpha-decaying isotopes is now a prerequisite for rare-event searches (e.g., dark-matter direct detection and neutrinoless double-beta decay) for which surface radiocontamination has become an increasingly important background. The BetaCage, a gaseous neon time-projection chamber, is a proposed ultra-sensitive (and nondestructive) screener for alpha- and beta-emitting surface contaminants to which existing screening facilities are insufficiently sensitive. Sensitivity goals are 0.1 betas per keV-m$^2$-day and 0.1 alphas per m$^2$-day, with the former limited by Compton scattering of photons in the screening samples and (thanks to tracking) the latter expected to be signal-limited; radioassays and simulations indicate backgrounds from detector materials and radon daughters should be subdominant. We report on details of the background simulations and detector design that provide the discrimination, shielding, and radiopurity necessary to reach our sensitivity goals for a chamber with a 95$\times$95 cm$^2$ sample area positioned below a 40 cm drift region and monitored by crisscrossed anode and cathode planes consisting of 151 wires each.Comment: 5 pages, 3 figures, Proceedings of Low Radioactivity Techniques (LRT) 2013, Gran Sasso, Italy, April 10-12, 201

Minimal access surgery compared with medical management for gastro-oesophageal reflux disease : five year follow-up of a randomised controlled trial (REFLUX)

Peer reviewedPublisher PD

Screening Surface Contamination with BetaCage

Existing screening facilities are insufficiently sensitive to meet the needs of rare‐event experiments for low‐energy electron emitters and alpha‐decaying isotopes. To provide such screening, the BetaCage will be a low‐background, atmospheric‐pressure neon drift chamber with unprecedented sensitivity to emitters of low‐energy electrons and alpha particles. Minimization of the detector mass and use of radiopure materials reduce background events. The chamber design accepts nearly all alphas and low‐energy electrons from the sample surface while allowing excellent rejection of residual backgrounds. A non‐radiopure prototype is under construction to test the design. The BetaCage will provide new infrastructure for rare‐event science as well as for a wider community that uses radioactive screening for areas including archaeology, biology, climatology, environmental science, geology, planetary science, and integrated‐circuit quality control

Possible unconventional superconductivity in substituted BaFe2_{2}As2_{2} revealed by magnetic pair-breaking studies

The possible existence of a sign-changing gap symmetry in BaFe$_{2}$As$_{2}$-derived superconductors (SC) has been an exciting topic of research in the last few years. To further investigate this subject we combine Electron Spin Resonance (ESR) and pressure-dependent transport measurements to investigate magnetic pair-breaking effects on BaFe$_{1.9}M_{0.1}$As$_{2}$ ($M=$ Mn, Co, Cu, and Ni) single crystals. An ESR signal, indicative of the presence of localized magnetic moments, is observed only for $M=$ Cu and Mn compounds, which display very low SC transition temperature ($T_{c}$) and no SC, respectively. From the ESR analysis assuming the absence of bottleneck effects, the microscopic parameters are extracted to show that this reduction of $T_{c}$ cannot be accounted by the Abrikosov-Gorkov pair-breaking expression for a sign-preserving gap function. Our results reveal an unconventional spin- and pressure-dependent pair-breaking effect and impose strong constraints on the pairing symmetry of these materials

Benchmarking network-based gene prioritization methods for cerebral small vessel disease

Network-based gene prioritization algorithms are designed to prioritize disease-associated genes based on known ones using biological networks of protein interactions, gene disease associations and other relationships between biological entities. Various algorithms have been developed based on different mechanisms, but it is not obvious which algorithm is optimal for a specific disease. To address this issue, we benchmarked multiple algorithms for their application in cerebral small vessel disease (cSVD). We curated protein-gene interactions (PGI) and gene-disease associations (GDA) from databases and assembled PGI networks and disease-gene heterogenous networks. A screening of algorithms resulted in seven representative algorithms to be benchmarked. Performance of algorithms was assessed using both leave-one-out cross-validation (LOOCV) and external validation with MEGASTROKE genome-wide association study (GWAS). We found that random walk with restart on the heterogeneous network (RWRH) showed best LOOCV performance, with median LOOCV rediscovery rank of 185.5 (out of 19,463 genes). The GenePanda algorithm had most GWAS-confirmable genes in top 200 predictions, while RWRH had best ranks for small vessel stroke associated genes confirmed in GWAS. In conclusion, RWRH has overall better performance for application in cSVD despite its susceptibility to bias caused by degree centrality. Choice of algorithms should be determined before applying to specific disease. Current pure network-based gene prioritization algorithms are unlikely to find novel disease-associated genes that are not associated with known ones. The tools for implementing and benchmarking algorithms have been made available and can be generalized for other diseases

Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease : 5-year follow-up of multicentre randomised trial (the REFLUX trial)

Peer reviewedPublisher PD

Changes in epidemiological patterns of sea lice infestation on farmed Atlantic salmon, Salmo salar L., in Scotland between 1996 and 2006

Analyses of a unique database containing sea lice records over an 11 year period provide evidence of changing infestation patterns in Scotland. The data, collected from more than 50 commercial Atlantic salmon farms, indicate that both species of sea lice commonly found in Scotland, Lepeophtheirus salmonis and Caligus elongatus, have declined on farms over the past decade. Reductions for both species have been particularly marked since 2001 when more effective veterinary medicines became available. Treatment data were also available in the database and these show a growing trend towards the use of the in feed medication emamectin benzoate (Slice), particularly in the first year of the salmon production cycle. However, this trend to wards single product use has not been sustained in 2006, the latest year for which data are available. There is some evidence of region to region variation within Scotland with the Western Isles experiencing higher levels of infestation. However, compared to the levels observed between 1996 and 2000, all regions have benefited from reduced lice infestation, with the overall pattern showing a particular reduction in the second and third quarters of the second year of production